<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00566839</url>
  </required_header>
  <id_info>
    <org_study_id>MED2112025</org_study_id>
    <secondary_id>enfis12022</secondary_id>
    <nct_id>NCT00566839</nct_id>
  </id_info>
  <brief_title>Randomized Comparison of Awake Nonresectional Versus Nonawake Resectional Lung Volume Reduction Surgery</brief_title>
  <official_title>Randomized Comparison of Thoracoscopic Lung Volume Reduction Surgery Performed by Resectional Surgical Technique Under General Anesthesia or by a Non-Resectional Technique in Awake Patients Under Sole Epidural Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rome Tor Vergata</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung volume reduction surgery is effective in improving pulmonary function and quality of&#xD;
      life in selected patients with severe emphysema although the morbidity of this surgical&#xD;
      procedure is still considerable. Morbidity is mainly addressed to general anesthesia-related&#xD;
      adverse effects and surgical trauma deriving from lung resection. Having developed an awake&#xD;
      nonresectional lung volume reduction surgery technique, which is performed under sole&#xD;
      thoracic epidural anesthesia, we have hypothesized that it could offer satisfactory clinical&#xD;
      results and reduced morbidity rate when compared with the conventional surgical procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is increasing scientific evidence that resectional lung volume reduction (LVR) can&#xD;
      induce long lasting clinical improvements in selected patients with upper-lobe predominant&#xD;
      emphysema and that clinical benefit and survival are better than those achieved with&#xD;
      maximized medical treatment. The most widely employed surgical technique entails unilateral&#xD;
      or bilateral staple resection of the most emphysematous lung tissue performed under general&#xD;
      anesthesia through open or thoracoscopic approaches.&#xD;
&#xD;
      However, the type of surgical approach did not modify the considerable procedure-related&#xD;
      morbidity, which can be mainly addressed to general anesthesia and surgical trauma deriving&#xD;
      from resection of emphysematous lung tissue. Indeed, following resectional LVR expected&#xD;
      mortality and pulmonary morbidity are 5.5% and 30%, respectively. Time spent for&#xD;
      postoperative recovering is often prolonged with about 30% of patients still hospitalized or&#xD;
      in rehabilitation facilities at 1 month and 15% still not at home 2 months after the&#xD;
      operation. As a result, the cost-effectiveness of LVR continue to be questioned.&#xD;
&#xD;
      In recent years, the concept of nonresectional LVR is being investigated and new&#xD;
      bronchoscopic approaches have been developed in an attempt of reducing the typical&#xD;
      shortcomings of resectional LVR. Within the framework of the proposed nonsurgical methods&#xD;
      which differ somewhat in physiopathologic bases and mechanism of LVR, a common denominator is&#xD;
      that, so far, all needed general anesthesia.&#xD;
&#xD;
      We have developed an awake nonresectional LVR surgery technique, which respects the basic&#xD;
      concepts of resectional LVR but adds some theoretical advantages and is performed under sole&#xD;
      thoracic epidural anesthesia.&#xD;
&#xD;
      Following an initial pilot study to assess feasibility and early results, we want to analyze&#xD;
      in a randomized fashion the perioperative morbidity and comprehensive 2-year results of&#xD;
      thoracoscopic lung volume reduction surgery performed by the awake nonresectional or nonawake&#xD;
      resectional surgical techniques.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date type="Actual">October 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced expiratory volume in one second</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Residual volume</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Medical research Council Dyspnea index</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial carbon dioxide tension (mmHg)</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial oxygen to fraction of inspired oxygen ratio (PaO2/FiO2)</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia satisfaction score (graded from 1=unsatisfactory to 4=Excellent)</measure>
    <time_frame>1 day (24h post-surgery)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six minute walking test distance (m)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short form 36-item quality of life physical function domain score</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index (Kg/m2)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pulmonary Emphysema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>awake nonresectional LVRS</intervention_name>
    <description>Thoracoscopic nonresectional lung volume reduction surgery carried out in awake patients under sole epidural anesthesia through plication of most emphysematous target areas of the lung</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nonawake resectional LVRS</intervention_name>
    <description>Thoracoscopic lung volume reduction surgery carried out under general anesthesia and one-lung ventilation through nonanatomic resection of the most emphysematous target areas of the lung</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Severe smoking-related emphysema with upper-lobe predominance&#xD;
&#xD;
          -  Severe disability (MMRC dyspnea grade&gt;=3) despite maximized medical therapy including&#xD;
             respiratory rehabilitation&#xD;
&#xD;
          -  No clinically significant sputum production, bronchiectasis or asthma&#xD;
             postbronchodilator forced expiratory volume in onee second (FEV1)&lt;40% predicted&#xD;
&#xD;
          -  Residual volume (RV)&gt;180% predicted at body plethysmography&#xD;
&#xD;
          -  Total Lung capacity&gt;120% predicted&#xD;
&#xD;
          -  No instable angina or ventricular arrythmia&#xD;
&#xD;
          -  Peak systolic pulmonary artery pressure &lt;50 mmHg at echocardiocolordoppler&#xD;
&#xD;
          -  Arterial carbon dioxide (PaCO2)&lt;50 mmHg&#xD;
&#xD;
          -  Diffusion capacity of carbon monoxide (DLCO)&gt; 20% predicted&#xD;
&#xD;
          -  Quit smoking since at least 4 months&#xD;
&#xD;
          -  ASA score&lt;=3&#xD;
&#xD;
          -  Body mass index &gt;18 &lt;29&#xD;
&#xD;
          -  No comorbid condition that would significantly increase operative risk or negatively&#xD;
             affect participation in a vigorous respiratory rehabilitation program&#xD;
&#xD;
          -  No neoplastic disease with life expectancy &lt; 12 months&#xD;
&#xD;
          -  No previous pleurodesis or thoracotomy in the more affected hemithorax&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Radiologic evidence of extensive pleural adhesions with pleural scarring and&#xD;
             calcifications on site targeted for LVRS&#xD;
&#xD;
          -  Patients refusal or noncompliance to thoracic epidural anesthesia and awake surgery&#xD;
&#xD;
          -  Patients refusal or noncompliance to general surgery and one-lung ventilation&#xD;
&#xD;
          -  Unfavorable anatomy for thoracic epidural anesthesia&#xD;
&#xD;
          -  Previous surgery of the cervical or upper thoracic spine&#xD;
&#xD;
          -  Compromised coagulation (thromboplastin time&lt;80%, prothrombin time&gt;40 sec, platelet&#xD;
             count&lt;100/nL or bleeding disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugenio Pompeo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thoracic Surgery Division, Policlinico Tor Vergata University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tommaso C Mineo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Thoracic Surgery Division, Policlinico Tor Vergata University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Policlinico Tor Vergata University</name>
      <address>
        <city>Rome</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Pompeo E, Marino M, Nofroni I, Matteucci G, Mineo TC. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. Ann Thorac Surg. 2000 Sep;70(3):948-53; discussion 954.</citation>
    <PMID>11016339</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Pompeo E, Rogliani P, Dauri M, Turani F, Bollero P, Magliocchetti N. Effect of lung volume reduction surgery for severe emphysema on right ventricular function. Am J Respir Crit Care Med. 2002 Feb 15;165(4):489-94.</citation>
    <PMID>11850341</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, Mineo TC; Pulmonary Emphysema Research group. Long-term outcome of staged versus one-stage bilateral thoracoscopic reduction pneumoplasty. Eur J Cardiothorac Surg. 2002 Apr;21(4):627-33; discussion 633.</citation>
    <PMID>11932158</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Ambrogi V, Pompeo E, Bollero P, Mineo D, Nofroni I; Pulmonary Emphysema Research Group. Body weight and nutritional changes after reduction pneumoplasty for severe emphysema: a randomized study. J Thorac Cardiovasc Surg. 2002 Oct;124(4):660-7.</citation>
    <PMID>12324722</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, De Dominicis E, Ambrogi V, Mineo D, Elia S, Mineo TC. Quality of life after tailored combined surgery for stage I non-small-cell lung cancer and severe emphysema. Ann Thorac Surg. 2003 Dec;76(6):1821-7.</citation>
    <PMID>14667591</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Ambrogi V, Pompeo E, Elia S, Mineo D, Bollero P, Nofroni I. Impact of lung volume reduction surgery versus rehabilitation on quality of life. Eur Respir J. 2004 Feb;23(2):275-80.</citation>
    <PMID>14979503</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Pompeo E, Mineo D, Rogliani P, Leonardis C, Nofroni I. Results of unilateral lung volume reduction surgery in patients with distinct heterogeneity of emphysema between lungs. J Thorac Cardiovasc Surg. 2005 Jan;129(1):73-9.</citation>
    <PMID>15632827</PMID>
  </reference>
  <reference>
    <citation>Tacconi F, Pompeo E, Mineo TC. Late-onset occult pneumothorax after lung volume-reduction surgery. Ann Thorac Surg. 2005 Dec;80(6):2008-12.</citation>
    <PMID>16305835</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Pompeo E, Mineo D, Tacconi F, Marino M, Sabato AF. Awake nonresectional lung volume reduction surgery. Ann Surg. 2006 Jan;243(1):131-6.</citation>
    <PMID>16371748</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Pompeo E, Mineo D, Ambrogi V, Ciarapica D, Polito A. Resting energy expenditure and metabolic changes after lung volume reduction surgery for emphysema. Ann Thorac Surg. 2006 Oct;82(4):1205-11.</citation>
    <PMID>16996909</PMID>
  </reference>
  <reference>
    <citation>Mineo TC, Pompeo E. Long-term results of tailored lung volume reduction surgery for severe emphysema. Clin Ter. 2007 Mar-Apr;158(2):127-33.</citation>
    <PMID>17566513</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, Mineo TC. Two-year improvement in multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity index after nonresectional lung volume reduction surgery in awake patients. Ann Thorac Surg. 2007 Dec;84(6):1862-9; discussion 1862-9.</citation>
    <PMID>18036900</PMID>
  </reference>
  <verification_date>October 2007</verification_date>
  <study_first_submitted>November 30, 2007</study_first_submitted>
  <study_first_submitted_qc>November 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2007</study_first_posted>
  <last_update_submitted>November 30, 2007</last_update_submitted>
  <last_update_submitted_qc>November 30, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2007</last_update_posted>
  <responsible_party>
    <name_title>Tommaso Claudio Mineo</name_title>
    <organization>Tor Vergata University</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>LVRS</keyword>
  <keyword>Awake surgery</keyword>
  <keyword>Thoracic epidural anesthesia</keyword>
  <keyword>One-lung ventilation</keyword>
  <keyword>Emphysema</keyword>
  <keyword>VATS</keyword>
  <keyword>Lung surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Emphysema</mesh_term>
    <mesh_term>Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

